ID
22425
Beschrijving
Bortezomib and CHOP in Patients With Advanced Stage Aggressive T Cell or Natural Killer (NK)/T Cell Lymphomas; ODM derived from: https://clinicaltrials.gov/show/NCT00374699
Link
https://clinicaltrials.gov/show/NCT00374699
Trefwoorden
Versies (1)
- 02-06-17 02-06-17 -
Geüploaded op
2 juni 2017
DOI
Voor een aanvraag inloggen.
Licentie
Creative Commons BY 4.0
Model Commentaren :
Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.
Itemgroep Commentaren voor :
Item Commentaren voor :
U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.
Eligibility Peripheral T-Cell Lymphomas NCT00374699
Eligibility Peripheral T-Cell Lymphomas NCT00374699
- StudyEvent: Eligibility
Beschrijving
Exclusion Criteria
Alias
- UMLS CUI
- C0680251
Beschrijving
Malignant Neoplasms | Basal cell carcinoma | Carcinoma in situ of uterine cervix
Datatype
boolean
Alias
- UMLS CUI [1]
- C0006826
- UMLS CUI [2]
- C0007117
- UMLS CUI [3]
- C0851140
Beschrijving
Comorbidity Serious
Datatype
boolean
Alias
- UMLS CUI [1,1]
- C0009488
- UMLS CUI [1,2]
- C0205404
Beschrijving
Pregnancy | Breast Feeding
Datatype
boolean
Alias
- UMLS CUI [1]
- C0032961
- UMLS CUI [2]
- C0006147
Beschrijving
Study Subject Participation Status
Datatype
boolean
Alias
- UMLS CUI [1]
- C2348568
Similar models
Eligibility Peripheral T-Cell Lymphomas NCT00374699
- StudyEvent: Eligibility
C1955906 (UMLS CUI [2])
C1275317 (UMLS CUI [3,1])
C0252409 (UMLS CUI [3,2])
C1514241 (UMLS CUI [3,3])
C0205132 (UMLS CUI [1,2])
C1265611 (UMLS CUI [1,3])
C0040405 (UMLS CUI [1,2])
C0860888 (UMLS CUI [1,2])
C0441468 (UMLS CUI [1,2])
C0031809 (UMLS CUI [1,2])
C0373595 (UMLS CUI [2])
C0007117 (UMLS CUI [2])
C0851140 (UMLS CUI [3])
C0205404 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2])